These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29783348)

  • 1. Pharmacogenetics in epilepsy treatment: sense or nonsense?
    Depondt C
    Per Med; 2008 Mar; 5(2):123-131. PubMed ID: 29783348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
    Depondt C; Shorvon SD
    Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical impact of pharmacogenetics on the treatment of epilepsy.
    Löscher W; Klotz U; Zimprich F; Schmidt D
    Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various pharmacogenetic aspects of antiepileptic drug therapy: a review.
    Mann MW; Pons G
    CNS Drugs; 2007; 21(2):143-64. PubMed ID: 17284096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model.
    Depondt C
    Acta Neurol Belg; 2006 Dec; 106(4):157-67. PubMed ID: 17323833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacogenomics of epilepsy.
    Franco V; Perucca E
    Expert Rev Neurother; 2015 Oct; 15(10):1161-70. PubMed ID: 26327193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy.
    Ferraro TN; Dlugos DJ; Buono RJ
    Pharmacogenomics; 2006 Jan; 7(1):89-103. PubMed ID: 16354127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
    Locharernkul C; Loplumlert J; Limotai C; Korkij W; Desudchit T; Tongkobpetch S; Kangwanshiratada O; Hirankarn N; Suphapeetiporn K; Shotelersuk V
    Epilepsia; 2008 Dec; 49(12):2087-91. PubMed ID: 18637831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
    Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E;
    Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Pharmacogenomics in Antiepileptic Drug Therapy: Current Status and Future Perspectives.
    Gambardella A; Labate A; Mumoli L; Lopes-Cendes I; Cendes F
    Curr Pharm Des; 2017; 23(37):5760-5765. PubMed ID: 28891449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common allergies do not influence the prevalence of cutaneous hypersensitivity reactions to antiepileptic drugs.
    Bosak M; Porębski G; Słowik A; Turaj W
    Epilepsy Res; 2017 Sep; 135():9-13. PubMed ID: 28552676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epilepsy pharmacogenetics : science or fiction?].
    Depondt C
    Med Sci (Paris); 2013 Feb; 29(2):189-93. PubMed ID: 23452606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why are antiepileptic drugs used for nonepileptic conditions?
    Bialer M
    Epilepsia; 2012 Dec; 53 Suppl 7():26-33. PubMed ID: 23153207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasticity of antiepileptic drug targets.
    Beck H
    Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current challenges in the treatment of epilepsy.
    Mattson RH
    Neurology; 1994 Jun; 44(6 Suppl 5):S4-9; discussion S31-2. PubMed ID: 8022538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
    Neuman MG; Cohen L; Nanau RM; Hwang PA
    Transl Res; 2012 May; 159(5):397-406. PubMed ID: 22500513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis for idiosyncratic reactions to antiepileptic drugs.
    Franciotta D; Kwan P; Perucca E
    Curr Opin Neurol; 2009 Apr; 22(2):144-9. PubMed ID: 19262378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B*1502 allele is associated with a cross-reactivity pattern of cutaneous adverse reactions to antiepileptic drugs.
    Wang J; Zhang J; Wu X; Yu P; Hong Z
    J Int Med Res; 2012; 40(1):377-82. PubMed ID: 22429379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
    Klein S; Bankstahl M; Löscher W
    Neuropharmacology; 2015 Mar; 90():53-62. PubMed ID: 25460186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.